Literature DB >> 32440181

Relationship Between the Consumption of Milk-Based Oils Including Butter and Kermanshah Ghee with Metabolic Syndrome: Ravansar Non-Communicable Disease Cohort Study.

Elham Ahmadi1, Hadi Abdollahzad2,3, Yahya Pasdar2, Shahab Rezaeian3, Jalal Moludi3, Seyed Mostafa Nachvak2, Roghayeh Mostafai2.   

Abstract

BACKGROUND: The prevalence of metabolic syndrome (MetS) in recent years has been growing in different societies, which may be due to lifestyle changes including changes in diet, in particular the consumption pattern of edible oils. The purpose of this study was to investigate the relationship between the consumption of animal oils including butter and Kermanshah ghee with MetS and its components in the adult population of Ravansar Non-Communicable Disease (RaNCD) cohort study.
METHODS: This cross-sectional study was carried out on 5550 adults aged 35-65 years using baseline data of Ravansar's prospective study center in Iran. MetS was defined according to the criteria of modified NCEP ATP III for Iranian adults. Relationship between the consumption of butter and Kermanshah ghee and MetS was analyzed by logistic regression model using STATA software.
RESULTS: In our study, the frequency of MetS was 31.40%. The mean body mass index and mean age were 27.1±4.6 kg/m2 and 47.6±8.2 years. The mean values of consumed butter and Kermanshah ghee were 3.3±1.8 and 5.1±2.3 g/day, respectively. After adjusting the confounding variables, the highest to the lowest quintile of butter and Kermanshah ghee consumption showed a reverse correlation with the MetS (OR = 0.7, 95% CI = 0.5-0.9) and (OR= 0.7, 95% CI=0.6-0.9), respectively.
CONCLUSION: This study revealed a reverse relationship between milk and Kermanshah ghee consumption with MetS and its components. Therefore, consumption of milk-based oils may be associated with lower cardiovascular risk factors.
© 2020 Ahmadi et al.

Entities:  

Keywords:  Kermanshah ghee; Ravansar cohort; butter; metabolic syndrome; oil

Year:  2020        PMID: 32440181      PMCID: PMC7211326          DOI: 10.2147/DMSO.S247412

Source DB:  PubMed          Journal:  Diabetes Metab Syndr Obes        ISSN: 1178-7007            Impact factor:   3.168


Background

Metabolic syndrome (MetS) refers to a cluster of metabolic disorders including insulin resistance, hypertension, abdominal obesity, dyslipidemia and systemic inflammation1 that increase the risk of non-communicable diseases such as type 2 diabetes (T2D) and cardiovascular diseases (CVD).2 According to the National Cholesterol Education Program (NCEP/ATP III) norms, the occurrence of MetS in the world varies from 8% to 43% in men and 7% to 56% in women3 and varies from 47.2% to 60.0% in Iran.4 The increasing prevalence of MetS can be attributed to changes in lifestyle, especially the diet.5 The amount and type of edible oils are among the most vital factors that regulate the health of our diet.6 One group of these oils is animal-origin oils, in particular dairy fat which contains saturated and trans-fatty acids (TFA).7 One study showed that SFAs may impair insulin sensitivity,8 however in a clinical study decreasing SFAs in diet did not affect insulin sensitivity in people with MetS.9 A recent review regarding the effects of dairy-derived SFAs consumption on the risk of MetS indicated that there is not enough evidence to support current dietary guidelines for reducing all dietary SFAs regardless of the dietary source, food matrix and composition.10 Evidence on the health effects of animal oils are inconclusive, their effects largely depend on the amount of saturated and trans fats in these products. While some studies indicate that animal oils increase the risk of cardiovascular diseases because of their high SFAs content,7,11 others have reported that trans-fatty acids in dairy fat do not increase the risk of cardiovascular diseases.12 The results of several studies point to that using animal oils significantly increases total cholesterol, HDL-C, and very low-density lipoprotein (VLDL) and decreases Apolipoprotein A (Apo-A) level.13,14 On the contrary, several studies have shown that consumption of animal oils as much as about 10% of total fat intake has no adverse effect on the lipid profile.15,16 In a large multicenter cohort study, the consumption of high-fat dairy products, butter, and yogurt showed a strong inverse relationship (linear dose-response) with the risk of MetS.17 In another study, however, using butter was directly correlated with the incidence of MetS.7 Butter and ghee are commonly used in many parts of Iran, including Kermanshah, where traditionally they account for a significant portion of total oil consumed by households.18 Despite the prevalent use of butter and ghee in the common diet of Kermanshah people and the inconsistency of the existing reports on the health effects of these products, there has been no study on the relationship between butter and Kermanshah ghee consumption and the risk of MetS in this population. To close this gap in the literature, this study investigated the relationship between the consumption of oils with animal origin including butter and Kermanshah ghee and MetS and its components in the adult population of Ravansar Non-Communicable Disease (RaNCD) cohort study.

Methods

Study Design

This cross-sectional study was performed on baseline data of 9951 permanent residents of Ravansar, including men and women aged 35–65 years that started in 2014. Ravansar is a city in Kermanshah province in west of Iran with a population of over 50,000 people, who are almost entirely of Kurdish ethnicity. This study is part of the PERSIAN (Prospective Epidemiological Research Studies of Iran) mega-cohort study. Details of the Ravansar cohort study protocol have been introduced in previous studies.19,20

Population

The study was designed as a census survey of participants in the RaNCD cohort study. Based on the inclusion criteria, 4401 of participants were excluded due to not having an usual daily energy intake (not at the range of 1.35–2.39 EI:BMR ratio) (n=2172), being diagnosed with non-communicable diseases for more than 1 year (n=2195), the lack of biochemical data (n=30), and the lack of data on oil consumption (n=4). Ultimately, the data of 5550 participants (2986 females and 2564 males) were investigated in the current study.

Data Collection

Demographic (age, gender, smoking and alcohol use, the history of diseases and medication), anthropometric and biochemical data, blood pressure, nutrition status of participants, and socioeconomic status (SES) including employment status; incomes, availability of electricity, access to safe drinking water and natural gas for heating and cooking, transport coverage; marital status; number and type of marriages (first-degree or second-degree familial marriage or none); spouse’s job; region of residency, number of domestic and international trips; access to landline and mobile phones, the internet and the extent of cell phone use were acquired.19,20 Physical activity was assessed using the standardized RaNCD cohort physical activity questionnaire, which measures this parameter in metabolic equivalent per day (MET-h/day).20 Data were collected by the relevant trained experts. A brief description of other data collection is provided in the following.

Food Intake Assessment

Food intake was studied using the Ravansar cohort food frequency questionnaire (FFQ) to which a list of foods commonly used in Kermanshah was added.21 The food quantities were converted to grams using the manual for household measures and analyzed in the software Nutritionist 4 to obtain nutritional parameters (micronutrient, macronutrient, and energy intake).22 The cooking oils of animal origin used in the study area are butter and ghee. To assess the relationship of the use of butter and ghee with the risk of MetS and its components, the intake of these products was classified into 5 quintiles from very low (quintile 1) to very high (quintile 5). We calculated the ratio of reported energy intake to BMR (rEI: BMR) to evaluate the validity of energy intake. To match the relative degree of under- and over-reporting of energy, we briefly used the values defined by Goldberg et al which proposed by FAO/WHO/UNU for assessing the energy expenditure. According to these surveys, EI:RMR ratio less than 1.35 was not consistent with usual dietary intake and considered underreporting.,23,24 In the current study we considered EI:BMR at ranges of 1.35–2.39 as normal reporting of energy intake.25

Biochemical and Blood Pressure Assessment

To evaluate the serum level of biochemical markers, blood samples were taken from the brachial vein after 12 hours of fasting. After centrifugation, serum samples were stored in the RaNCD cohort study laboratory at −72°C until analysis.19 Serum total triglyceride (TG), total cholesterol, and High-density lipoprotein (HDL-C) levels were measured by routine laboratory methods26 (Pars Azmoon kit, Pars Azmoon Inc., Tehran, Iran). The Friedewald equation was used to calculate low-density lipoprotein (LDL-C) levels.27 Fasting blood glucose (FBG) was measured using glucose oxidase test. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured using a Reister sphygmomanometer after sitting for at least 4–5 minutes. This measurement was performed twice for each hand with 10-minute intervals and the average of the measurements was recorded as the person’s final blood pressure.19

Anthropometric Assessment

Assessed anthropometric parameters included height, weight, BMI, waist circumference, and hip circumference. Weight was measured with minimal clothing and without shoes using the InBody 770 device (Inbody Co., Seoul, Korea). Height was measured using the BSM 370 automatic measuring device (Biospace Co., Seoul, Korea) in the standing position without shoes with the shoulders held in their normal position. BMI was calculated. Waist and hip circumferences were also measured according to RaNCD protocols.19,20

Definition of Metabolic Syndrome

In the present study, MetS was defined as meeting at least three criteria specified in the Modified NCEP ATP III for Iranian adults.28 These criteria are as follows: FBG ≥100 mg/dl or taking blood glucose-lowering medications Serum TG ≥150 mg/dl or taking TG-lowering medications HDL-C ≤40 mg/dl in men and ≤50 mg/dl in women or taking HDL-C boosting medications SBP ≥130 mm/Hg or DBP ≥ 85 mm/Hg or taking blood pressure-lowering medications Waist circumference ≥95cm for both genders.

Definition of Kermanshah Ghee

According to the definition of International Dairy Federation,29 ghee is a dairy product made from milk, cream or butter of cattle, sheep, or goat that contains 65% SFA and 33% MUFA.30 Kermanshah ghee is a type of ghee produced by traditional methods in rural areas of Kermanshah province. To prepare this ghee, one first ferments the milk to produce yogurt and keeps it at room temperature for one night, then shakes the yogurt for a few hours in a classic round churning machine to separate the butterfat from the yogurt. After melting this butterfat and removing its impurities, the remained fat is called ghee that contains about 60.4% SFA, 31.4% MUFA, 4% PUFA, and 1.5% TFA.31

Data Analysis

Data were analyzed using the software STATA 14. The analysis of covariance (ANCOVA) was used to compare butter/ghee consumption quintiles (energy-, age-, and gender-adjusted) in terms of intake of nutrients and food groups. Upon encountering significant differences, the Tukey post hoc test was used to make pairwise comparisons between the groups. Logistic regression was used to check whether there is any correlation between the use of butter/ghee and the odds of having MetS. The correlation between the use of butter/ghee and the components of MetS was assessed by the use of linear regression. Regression models were used to eliminate the effect of confounding variables. In addition to the crude model, the analysis was performed with three other models with adjustment for significant variables: Model 1: age, gender, education level, marital status, economic status, and physical activity Model 2: Additional adjustment for dietary intakes including fruits, vegetables, legumes, bread and cereals, dairy products, sugars, miscellaneous foods (spices and food supplements), oils and oilseeds, percentage of energy intake from fat except butter or ghee. Model 3: Additional adjustment for BMI>30 and hip circumference In all multivariate models, the first quintile was considered as the reference. The relationship between the consumption of butter/ghee and the study variables was assessed using the crude and adjusted odds ratios taken from the logistic regression model at 95% confidence level. For all tests, the level of statistical significance was P-value<0.05.

Results

Of the 5550 persons whose data met the inclusion/exclusion criteria, 53.8% were female and the rest were male. The mean age of the subjects was 47.6±8.19 years. The prevalence of MetS was 31.42%. The mean intake of butter and Kermanshah ghee was 1.85±3.32 and 2.32±5.13 g/day, respectively. The demographic characteristics of the subjects across quintiles of butter/ghee intakes after adjustment for total energy intake are given in Table 1. As this table shows, people in the highest quintile of butter intake had higher mean age, higher physical activity, and lower BMI than those in the lowest quintile. People in the highest quintile of ghee intake were mostly women and had lower BMI and obesity and more physical activity than the lowest quintile. Also, the use of butter and Kermanshah ghee had a significant correlation with socioeconomic status.
Table 1

Basic Characteristics of Participants of the Ravansar Prospective Study by Quintiles of Energy-Adjusted Amounts of Butter and Kermanshah Ghee (Mean ± Standard Deviations or Percentages)

VariableButter Quintiles*P-valueKermanshah Ghee QuintilesP-value*
Q1 (<0.20 g)Q2 (0.20–0.68 g)Q3 (>0.68–1.9 g)Q4 (>1.9–7.3 g)Q5 (>7.3g)Q1 (<0.09g)Q2 (0.09–0.5 g)Q3 (>0.5–1.9 g)Q4 (>1.9–9.5g)Q5 (>9.5g)
Participants (n)11991021118511969491703110611661462701
Age (years)47.60±0.2346.39±0.2547.11±0.2348.17±0.2348.89±0.260.0347.97±0.1946.23±0.3246.77±0.2347.81±0.2748.64±0.240.21
BMI (kg/m2)27.43±0.1327.32±0.1426.96±0.1326.88±0.1326.82±0.150.0227.32±0.1127.30±0.1827.13±0.1326.98±0.1526.64±0.130.001
Physical activity (MET-h/day)40.53±0.2240.81±0.2440.80±0.2241.05±0.2241.53±0.250.0340.72±0.1941.02±0.3140.70±0.2240.63±0.2641.67±0.230.01
Hip circumference [26]102.23±0.25102.55±0.27102.16±0.25102.03±0.25101.97±0.280.96101.28±0.21102.79±0.34102.77±0.24102.73±0.29102.13±0.260.08
Obese (%)27252221230.252726232220<0.001
Female (%)52515255570.1052524955580.01
Socioeconomic status** (%)0.004<0.001
 Very weak24.5316.8219.9821.8516.8234.9312.2718.5214.3019.98
 Weak24.1918.0520.4219.8917.4432.2510.2521.5615.9519.98
 Middle20.2620.8121.5522.1915.1930.7611.4222.9315.1019.80
 Good20.5317.1923.9720.6317.6830.5511.4923.0816.6018.27
 Very good17.8819.2721.2323.1818.4424.2110.8925.7018.6220.58
Current daily smokers (%)19201920180.9820182118190.82
Alcohol use (%)465650.39657540.21
Family history of diabetes (%)36384339400.9438404143370.99
Family history of stroke (%)18171918190.9418201819180.99

Notes: Obesity: BMI ≥ 30 kg/m2. *A significant level comparison the highest quintile with the lowest quintile (Tukey post hoc test) and (ANCOVA). **Analyzed by Kruskal–Wallis test. P<0.05 is considered as a significant level (bold values).

Abbreviations: Q, Quintile; BMI, body mass index; MET, metabolic equivalent.

Basic Characteristics of Participants of the Ravansar Prospective Study by Quintiles of Energy-Adjusted Amounts of Butter and Kermanshah Ghee (Mean ± Standard Deviations or Percentages) Notes: Obesity: BMI ≥ 30 kg/m2. *A significant level comparison the highest quintile with the lowest quintile (Tukey post hoc test) and (ANCOVA). **Analyzed by Kruskal–Wallis test. P<0.05 is considered as a significant level (bold values). Abbreviations: Q, Quintile; BMI, body mass index; MET, metabolic equivalent. Table 2 shows the intake of nutrients and food groups in the butter/ghee consumption quintiles after adjustment for total energy intake, age, and gender. As can be seen, people in the highest quintile of butter consumption had higher cholesterol and intakes of energy, protein, fat, SFA, dairy, oils and oilseeds and lower intakes of carbohydrates, fiber, PUFA, vegetables, bread and cereals, and miscellaneous foods than the lowest quintile. Individuals in the highest quintiles of Kermanshah ghee consumption had higher cholesterol and intakes of energy, protein, fat, SFA, dairy, oils and oilseeds and lower intakes of carbohydrates, MUFA, PUFA, fiber, vegetables, legumes, bread and cereals and miscellaneous foods than the first quintile.
Table 2

Dietary Intakes of Participants of the Ravansar’s Prospective Study by Quintiles of Energy, Age, Gender-Adjusted Amounts of Butter and Kermanshah Ghee (Mean ± Standard Deviations)

VariableButter QuintilesP-value*Kermanshah Ghee QuintilesP-value*
Q1 (<0.20 g)Q2 (0.20–0.68 g)Q3 (>0.68–1.9 g)Q4 (>1.9–7.3 g)Q5 (>7.3g)Q1 (<0.09g)Q2 (0.09–0.5 g)Q3 (>0.5–1.9 g)Q4 (>1.9–9.5g)Q5 (>9.5g)
Participants (n)11991021118511969491703110611661462701
Total energy1 (kcal/d)2709.04±19.022759.51±20.632853.46±19.123037.17±19.043193.70±21.39<0.0012854.15±16.332772.61±26.962845.07±19.212946.19±22.573082.17±20.37<0.001
Carbohydrate (% of total energy)59.74±0.1759.97±0.1859.55±0.1758.50±0.1757.3±0.19<0.00159.27±0.1460.07±0.2359.75±0.1658.70±0.1957.74±0.18<0.001
Protein (% of total energy)12.70±0.0612.90±0.0713.10±0.0613.32±0.0613.52±0.07<0.00112.74±0.0512.85±0.0913.18±0.0613.39±0.0713.46±0.06<0.001
Fat (% of total energy)27.54±0.1527.12±0.1727.33±0.1528.16±0.1529.08±0.17<0.00127.98±0.1327.07±0.2127.05±0.1527.89±0.1828.78±0.160.002
Dietary fiber (g/d)26.84±0.1725.93±0.1925.68±0.1725.54±0.1725.40±0.20<0.00127.32±0.1425.86±0.2425.43±0.1725.35±0.2024.68±0.18<0.001
Cholesterol (mg/d)243.44±3.22252.88±3.48254.12±3.21255.87±3.21273.58±3.65<0.001247.43±2.67240.02±4.42253.79±3.15258.22±3.70275.54±3.36<0.001
SFA (% of total energy)8.1±0.68.3±0.68.5±0.69.0±0.69.9±0.7<0.0018.3±0.58.2±0.88.5±0.68.9±0.79.7±0.6<0.001
MUFA (% of total energy)9.4±0.69.2±0.79.2±0.69.4±0.69.5±0.70.969.6±0.59.2±0.99.1±0.69.4±0.79.2±0.70.005
PUFA (% of total energy)6.7±0.56.5±0.56.4±0.56.5±0.56.3±0.6<0.0016.8±0.46.5±0.76.3±0.56.4±0.66.3±0.5<0.001
Food Groups
Fruit (kcal/d)162.18±3.22149.92±3.4155.61±3.21160.83±3.21173.98±3.650.11170.90±2.68151.39±4.43150.89±3.15159.55±3.70159.86±3.360.07
Vegetables (kcal/d)262.12±4.13256.41±4.46254.27±4.12249.08±4.11241.86±4.680.01267.96±3.43251.37±5.67243.14±4.03248.15±4.74246.33±4.30<0.001
Meat and its products (kcal/d)184.74±3.05182.01±3.29186.70±3.04181.61±3.04182.99±3.450.99186.25±2.53170.59±4.19180.33±2.98184.93±3.50189.92±3.180.89
Legumes (kcal/d)67.65±1.8361.81±1.9863.85±1.8474.35±1.8372.86±2.050.3277.50±1.5359.08±2.5263.63±1.8064.25±2.1166.80±1.91<0.001
Bread and cereals (kcal/d)1245.52±10.251272.89±11.061248.03±10.221186.53±10.211118.34±11.61<0.0011211.30±8.561279.8±14.151258.49±10.071204.13±11.821151.89±10.74<0.001
Dairy products (kcal/d)306.55±6.89335.10±7.44347.24±6.87387.55±6.87412.70±7.81<0.001305.71±5.73347.88±9.47369.27±6.74387.12±7.92399.04±7.19<0.001
Oils and oilseeds (kcal/d)352.7±4.7334.8±5.1338.1±4.7352.1±4.7387.5±5.3<0.001360.4±3.9330.5±6.5330.7±4.6348.7±5.4378.3±4.9<0.001
Sugars (kcal/d)152.57±3.48160.05±3.75158.51±3.47157.09±3.46164.25±3.940.18153.06±2.89159.70±4.78160.36±3.40155.66±3.99164.87±3.630.08
Others2 (kcal/d)127.01±2.73112.31±2.94115.02±2.72120.56±2.71115.13±3.090.03129.01±2.26114.77±3.74111.85±2.66115.77±3.13113.11±2.84<0.001

Notes: 1Energy mean is adjusted in terms of age and sex. 2Others are miscellaneous food products, spices and food supplements. *A significant level comparison the highest with the lowest quintile (Tukey post hoc test) and (ANCOVA). P<0.05 is considered as a significant level (bold values).

Abbreviations: Q, quintile; SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid.

Dietary Intakes of Participants of the Ravansar’s Prospective Study by Quintiles of Energy, Age, Gender-Adjusted Amounts of Butter and Kermanshah Ghee (Mean ± Standard Deviations) Notes: 1Energy mean is adjusted in terms of age and sex. 2Others are miscellaneous food products, spices and food supplements. *A significant level comparison the highest with the lowest quintile (Tukey post hoc test) and (ANCOVA). P<0.05 is considered as a significant level (bold values). Abbreviations: Q, quintile; SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid. The odds ratio of the MetS and the geometric means of its components in the butter/ghee consumption quintiles are shown in Tables 3 and 4. In both crude and adjusted models, the geometric mean of TG in the highest quintile of butter consumption was significantly lower than that in the lowest quintile (P<0.05). A similar statistically significant relation was observed for the geometric mean of FBG in the crude model and Models 1 and 2. In Model 3 however (adjusted for BMI and hip circumference), this relation was not statistically significant (P = 0.09). In all models, the geometric mean of HDL-C significantly increased with the quintile (P <0.05). There was no significant difference between the butter consumption quintiles in terms of the geometric mean of DBP or waist circumference (P> 0.05). Only Model 1 showed a significant difference between the geometric means of SBP in the highest and lowest butter consumption quintiles (P <0.039) and even this difference became insignificant after further adjustment for confounding variables. In the crude model and Models 1 and 2, the odds of having MetS significantly decreased with the increase of butter consumption (P = 0.001). In Model 3, decrease in the odds of developing MetS was less pronounced but still statistically significant (26% difference between the highest and lowest quintiles with P=0.007, 95% CI=0.59–0.92, OR=0.74)
Table 3

Multivariate Adjusted Odds Ratio (95% CI) for Metabolic Syndrome and Geometric Means of Its Components Across Quintile Categories of Butter Among Participants of the Ravansar Prospective Study

VariableButter Quintiles*P- value
Q1 (n=1199)Q2 (n=1021)Q3 (n=1185)Q4 (n=1196)Q5 (n=949)
TG1(mg/dl)
 Crude140.11±2.28130.81±2.47134.24±2.29136.02±2.28126.72±2.56< 0.001
 Model 1140.13±2.25131.05±2.44134.27±2.26135.76±2.25126.73±2.53< 0.001
 Model 2139.66±2.30130.83±2.46134.01±2.26135.69±2.27127.98±2.660.003
 Model 3137.54±2.23129.50±2.38134.57±2.19137.01±2.19129.74±2.570.026
FBG1(mg/dl)
 Crude93.01±0.4791.54±0.5191.84±0.4792.56±0.4791.56±0.530.042
 Model 192.96±0.4791.76±0.5191.94±0.4792.44±0.4791.41±0.530.030
 Model 293.11±0.4891.71±0.5191.88±0.4792.36±0.4791.46±0.550.006
 Model 392.89±0.4791.55±0.5091.95±0.4692.51±0.4691.64±0.540.018
DBP1 (mmHg)
 Crude69.98±0.2868.90±0.3069.26±0.2869.34±0.2869.64±0.310.435
 Model 169.89±0.2769.15±0.2969.39±0.2769.24±0.2769.45±0.300.291
 Model 269.78±0.2869.18±0.2969.41±0.2769.23±0.2769.54±0.320.961
 Model 369.54±0.2769.03±0.2969.48±0.2669.38±0.2669.74±0.310.346
SBP1 (mmHg)
 Crude108.58±0.48106.70±0.52107.11±0.49107.17±0.48107.46±0.540.128
 Model 1108.41±0.46107.33±0.49107.39±0.46106.90±0.45106.98±0.510.039
 Model 2108.18±0.47107.32±0.50107.39±0.46106.91±0.46107.27±0.540.398
 Model 3107.80±0.45107.07±0.48107.50±0.44107.15±0.44107.58±0.520.921
HDL-C1(mg/dl)
 Crude46.39±0.3346.92±0.3546.76±0.3347.38±0.3347.94±0.370.002
 Model 146.09±0.3147.03±0.3346.85±0.3147.47±0.3147.98±0.35< 0.001
 Model 246.14±0.3146.90±0.3446.74±0.3147.52±0.3148.13±0.360.002
 Model 346.45±0.3047.08±0.3346.66±0.3047.33±0.3047.88±0.350.034
WC1(cm)
 Crude96.74±0.3096.74±0.3396.36±0.3096.62±0.3096.56±0.340.690
 Model 196.65±0.3096.72±0.3296.36±0.3096.63±0.3096.67±0.330.964
 Model 296.96±0.3096.85±0.3296.34±0.3096.47±0.3096.38±0.350.300
 Model 396.58±0.1496.47±0.1596.51±0.1396.76±0.1496.69±0.160.905
**MetS2
 Crude10.74(0.62–0.89)0.77(0.65–0.91)0.80(0.68–0.95)0.72(0.60–0.87)0.001
 Model 110.76(0.63–0.91)0.78(0.65–0.93)0.80(0.67–0.95)0.72(0.60–0.87)0.001
 Model 210.76(0.63–0.91)0.78(0.65–0.93)0.78(0.65–0.93)0.71(0.58–0.87)0.001
 Model 310.74(0.60–0.90)0.82(0.67–0.99)0.84(0.69–1.03)0.74(0.59–0.92)0.007

Notes: 1Geometric mean± standard error. 2Odds ratio (95% confidence interval). *A significant level comparison the highest quintile with the lowest quintile of butter (logistic and linear regression). **A significant level of additive or decreasing trend in quintiles of butter (p-trends for MetS were significant in all models except model3). p <0.05 was considered as a significant level (bold values). Model1 was adjusted for age (in y), physical activity (continuous), socioeconomic status (categorical), current use of medications (except use of hypertriglyceridemic, hypertensive and hyperglycemic medications), Model2 was adjusted for variables in Model 1 and for dietary intakes including vegetables, bread and cereals, dairy products, others (spices and food supplements), oils and oilseeds, percentage of energy from fat except butter. Model3 was adjusted for variables in Model 2 and for BMI and Hip circumference which may be mediators as well as confounders (continuous).

Abbreviations: Q, quintile; TG, triglyceride; FBG, fasting blood glucose; DBP, diastolic blood pressure; SBP, systolic blood pressure; HDL-C, high-density lipoprotein; WC, waist circumference; MetS, metabolic syndrome.

Table 4

Multivariate Adjusted Odds Ratio (95% CI) for Metabolic Syndrome and Geometric Means of Its Components Across Quintile Categories of Kermanshah Ghee Among Participants of the Ravansar Prospective Study

VariableKermanshah Ghee Quintiles*P- value
Q1 (n=1703)Q2 (n=1106)Q3 (n=1166)Q4 (n=1462)Q5 (n=701)
TG1 (mg/dl)
 Crude141.27±1.91129.52±3.15134.27±2.24129.04±2.64128.86±2.38< 0.001
 Model 1140.76±1.89130.50±3.11133.59±2.22129.07±2.61129.85±2.36< 0.001
 Model 2140.43±1.93130.04±3.13133.49±2.23128.96±2.61130.82±2.440.032
 Model 3137.78±1.89129.28±3.03133.33±2.16130.91±2.54133.96±2.370.405
FBG1 (mg/dl)
 Crude91.47±0.3993.28±0.6592.37±0.4692.97±0.5591.62±0.490.815
 Model 191.36±0.3993.64±0.6592.49±0.4692.91±0.5491.52±0.490.805
 Model 291.62±0.4093.55±0.6592.38±0.4692.76±0.5491.40±0.500.770
 Model 391.48±0.4093.40±0.6492.29±0.4592.90±0.5391.70±0.500.444
DBP1 (mmHg)
 Crude70.73±0.2369.13±0.3968.79±0.2769.35±0.3268.37±0.29< 0.001
 Model 170.56±0.2269.45±0.3769.00±0.2669.35±0.3168.22±0.28< 0.001
 Model 270.53±0.2369.52±0.3869.09±0.2769.33±0.3168.14±0.29< 0.001
 Model 370.22±0.2369.44±0.3769.08±0.2669.56±0.3168.50±0.28< 0.001
SBP1 (mmHg)
 Crude109.44±0.40107.05±0.67106.80±0.47107.18±0.56105.40±0.50< 0.001
 Model 1109.10±0.38107.85±0.63107.23±0.45107.11±0.53105.04±0.48< 0.001
 Model 2109.03±0.39107.92±0.63107.33±0.45107.09±0.53105.01±0.49< 0.001
 Model 3108.66±0.38107.75±0.61107.26±0.44107.39±0.51105.54±0.48< 0.001
HDL-C1(mg/dl)
 Crude45.34±0.2747.40±0.4546.86±0.3248.27±0.3848.72±0.34< 0.001
 Model 145.28±0.2647.35±0.4247.26±0.3048.21±0.3548.43±0.32< 0.001
 Model 245.42±0.2647.22±0.4347.11±0.3048.17±0.3648.49±0.33< 0.001
 Model 345.90±0.2647.29±0.4147.08±0.2947.84±0.3548.01±0.320.013
WC1 (cm)
 Crude95.70±0.2596.81±0.4297.11±0.3097.53±0.3596.55±0.320.040
 Model 195.62±0.2596.95±0.4197.20±0.2997.35±0.3496.64±0.310.012
 Model 295.82±0.2596.97±0.4197.18±0.2997.21±0.3496.46±0.320.089
 Model 396.21±0.1296.43±0.1996.67±0.1397.16±0.1696.78±0.150.007
**MetS2
 Crude10.78(0.64–0.95)0.89(0.76–1.04)0.78(0.66–0.93)0.71(0.60–0.84)< 0.001
 Model 110.81(0.66–0.99)0.90(0.77–1.06)0.77(0.64–0.93)0.78(0.61–0.99)< 0.001
 Model 210.82(0.67–1.01)0.91(0.78–1.07)0.78(0.65–0.93)0.72(0.61–0.85)< 0.001
 Model 310.81(0.66–0.99)0.90(0.77–1.06)0.77(0.64–0.93)0.78(0.61–0.99)0.045

Notes: 1Geometric mean± standard error. 2Odds ratio (95% confidence interval). *A significant level comparison the highest quintile with the lowest quintile of Kermanshah ghee (logistic and linear regression). **A significant level of additive or decreasing trend in quintiles of Kermanshah ghee (p-trends for MetS were significant in all models). p <0.05 was considered as a significant level (bold values). Model1 was adjusted for gender (male/female), physical activity (continuous), socioeconomic status (categorical), current use of medications (except use of hypertriglyceridemic, hypertensive and hyperglycemic medications), Model2 was adjusted for variables in Model 1 and for dietary intakes including fruits, vegetables, legumes, bread and cereals, dairy products, sugars, others (spices and food supplements), oils and oilseeds, percentage of energy from fat except ghee. Model3 was adjusted for variables in Model 2 and for BMI and Hip circumference which may be mediators as well as confounders (continuous).

Abbreviations: Q, quintile; TG, triglyceride; FBG, fasting blood glucose; DBP, diastolic blood pressure; SBP, systolic blood pressure; HDL-C, high-density lipoprotein; WC, waist circumference; MetS, metabolic syndrome.

Multivariate Adjusted Odds Ratio (95% CI) for Metabolic Syndrome and Geometric Means of Its Components Across Quintile Categories of Butter Among Participants of the Ravansar Prospective Study Notes: 1Geometric mean± standard error. 2Odds ratio (95% confidence interval). *A significant level comparison the highest quintile with the lowest quintile of butter (logistic and linear regression). **A significant level of additive or decreasing trend in quintiles of butter (p-trends for MetS were significant in all models except model3). p <0.05 was considered as a significant level (bold values). Model1 was adjusted for age (in y), physical activity (continuous), socioeconomic status (categorical), current use of medications (except use of hypertriglyceridemic, hypertensive and hyperglycemic medications), Model2 was adjusted for variables in Model 1 and for dietary intakes including vegetables, bread and cereals, dairy products, others (spices and food supplements), oils and oilseeds, percentage of energy from fat except butter. Model3 was adjusted for variables in Model 2 and for BMI and Hip circumference which may be mediators as well as confounders (continuous). Abbreviations: Q, quintile; TG, triglyceride; FBG, fasting blood glucose; DBP, diastolic blood pressure; SBP, systolic blood pressure; HDL-C, high-density lipoprotein; WC, waist circumference; MetS, metabolic syndrome. Multivariate Adjusted Odds Ratio (95% CI) for Metabolic Syndrome and Geometric Means of Its Components Across Quintile Categories of Kermanshah Ghee Among Participants of the Ravansar Prospective Study Notes: 1Geometric mean± standard error. 2Odds ratio (95% confidence interval). *A significant level comparison the highest quintile with the lowest quintile of Kermanshah ghee (logistic and linear regression). **A significant level of additive or decreasing trend in quintiles of Kermanshah ghee (p-trends for MetS were significant in all models). p <0.05 was considered as a significant level (bold values). Model1 was adjusted for gender (male/female), physical activity (continuous), socioeconomic status (categorical), current use of medications (except use of hypertriglyceridemic, hypertensive and hyperglycemic medications), Model2 was adjusted for variables in Model 1 and for dietary intakes including fruits, vegetables, legumes, bread and cereals, dairy products, sugars, others (spices and food supplements), oils and oilseeds, percentage of energy from fat except ghee. Model3 was adjusted for variables in Model 2 and for BMI and Hip circumference which may be mediators as well as confounders (continuous). Abbreviations: Q, quintile; TG, triglyceride; FBG, fasting blood glucose; DBP, diastolic blood pressure; SBP, systolic blood pressure; HDL-C, high-density lipoprotein; WC, waist circumference; MetS, metabolic syndrome. In the crude model and Models 1 and 2, the geometric mean of TG in the highest quintile of Kermanshah ghee consumption was significantly lower than that in the lowest quintile (P <0.05), but in Model 3 this difference although present was insignificant (P=0.405). In all models, the geometric mean of SBP and DBP decreased (P <0.001) and the geometric mean of HDL-C increased (P <0.001) with the increase of ghee consumption. None of the models showed a significant difference between the highest and lowest quintiles of ghee consumption in terms of the geometric mean of FBG (P> 0.05). In all of the models, the geometric mean of waist circumference in the highest Kermanshah ghee quintiles was significantly lower than that in the lowest quintile (P <0.001). In the crude model and Models 1 and 2, the odds of having MetS significantly decreased with the increase of ghee consumption (P <0.001). In Model 3 (adjustment of hip circumference and BMI), this relation was weaker but still significant (22% difference between the highest and lowest quintiles with P=0.045, 95% CI=0.61–0.99, OR=0.78).

Discussion

In this cross-sectional study on the adult population of Ravansar Non-Communicable Disease (RaNCD) cohort, we observed a strong and inverse relationship with a linear dose–response pattern between the consumption of Kermanshah ghee and butter (ghee/butter) with the odds of having MetS after adjusting of cofounders. Also, some components of MetS improved significantly with the greater consumption of ghee/butter. The present study showed that with increasing the Kermanshah ghee intake, DBP, SBP and waist circumference decreased and HDL-C increased significantly. Mahmoudifard et al reported that a ghee-containing diet significantly reduced TG levels and increased HDL.29 Other authors indicated that ghee as compared to sunflower oil decreases the weight and oxidative stress and had protective effects on the liver in rats.32 Also, long-term (5 months) consumption of yogurt butter oil as compared to flaxseed oil had no adverse effect on lipid profile and liver function in rats.33 The Possible mechanism of HDL elevation with consumption of Kermanshah ghee could be related to high levels of MUFA, especially oleic acid in this product.34 Researches have shown that MUFA-rich diets are associated with lower blood pressure.35 The decrease in plasma TG can be attributed to the antiatherogenic effect of conjugated linoleic acid (CLA) in milk fat. Loss of weight and subsequent reduction in waist circumference can be due to the high amounts of SFA and short- and medium-chain TG that are directly transported through the bloodstream to the liver and prevent obesity by increasing PPARγ gene expression. Also, CLA in milk fat can prevent from obesity by reducing the accumulation of visceral and ectopic fat.36 Hosseini et al found out rabbits receiving an animal oil diet had higher total cholesterol and LDL levels than those fed with hydrogenated and olive oils.15 Also, another study showed that replacement of 10% of the diet with animal oil for 4 weeks had no effect on total cholesterol level and hepatic lipid peroxidation but increased serum TG.16 Najafi et al reported that consumption of 30 grams of Kermanshah ghee per day instead of other oils for 1 month had no significant effect on serum lipid profile of healthy men.37 The discrepancy between our results and some of the previous reports may be attributed to the differences in the processing methods of ghee production. Kermanshah ghee is traditionally produced from yogurt (fermented dairy products) and has different fatty acids pattern than butter and oils that are directly extracted from milk, its production process results in higher amounts of short- and medium-chain fatty acids and lower amounts of cholesterol and long-chain fatty acids.31 In the current study with increasing butter intake the TG and FBG levels decreased significantly. Also, a positive relationship with a monotonic trend was observed between butter intake and elevation of HDL-C levels. The odds of having MetS significantly decreased with more consumption of butter. A prospective study indicated that high-fat dairy consumption was inversely associated with DBP, SBP, total cholesterol, and increased HDL level.17 Also, in a cross-over study, the consumption of dairy products for 6 weeks improved liver function and systemic inflammation among individuals with MetS.38 Another study also indicated that high intake of dairy fat decreases the risk of T2D and cardiovascular diseases.39 A meta-analysis has also reported that butter consumption significantly decreases the average incidence of T2D but is not associated with CVD events.40 In another meta-analysis of clinical trials, high-fat dairy consumption was inversely associated with T2D and the low-fat dairy product intake was related to the risk of the disease.41 In a study by Gagliardi et al on people with MetS, butter consumption for 5 weeks did not show any significant effect on HDL-C, TG, SBP, DBP, and inflammatory markers.42 The study of Ari Palomäki et al on people with MetS showed that using a butter-containing diet lasting for 6 to 8 weeks made no significant difference in HDL-C, TG, and FBG levels, however, increased DBP and SBP although the changes were not statistically significant.43 Regarding the possible causes and mechanisms responsible for our findings as well as the similar investigations, it can be argued that in addition to the content of butter that 50% of its dry weight is made of SFAs44 SFAs with an odd number of carbon atoms, which are mostly found in dairy fats such as butter, increase the fluidity of the vascular cell membrane and are associated with a reduced risk of T2D and MetS.39 Butter also contains short- and medium-chain SFAs such as lauric acid and myristic acid, which are known to have protective effects against T2D.44 Trans-palmitoleic acid, which is a biomarker of dairy fat and butter consumption, is inversely associated with T2D.35 Also, a research has shown that the butyrate of butter induces insulin sensitivity45 and its CLA has beneficial effects on metabolic diseases.36 Conversely, Lichtenstein et al found that consumption of butter was associated with increased FBG and HDL-C, although it had no effect on SBP and DBP34 Compared to present study, Lichtenstein et al study was performed on older population (mean age: 67 years) with a large percentage of postmenopausal women; it can be claimed that hormonal changes are associated with increased insulin resistance. Judd et al found that butter intake in adults with normal blood lipid levels has no effect on HDL-C and TG but can increase total cholesterol.44 As we know SFA consumption can increase both HDL-C and LDL-C. In Judd’s study, more than 20% of consumed calorie was from SFA, but in our study even in the highest quintiles, SFA accounted for less than 10% of daily intake of calories. In a 28-day interventional study on postmenopausal women, the butter group with 20% SFA content in their diet had significantly higher total cholesterol and LDL-C than the olive oil group consuming 10% SFA; there was no difference between two groups in terms of DBP and SBP, FBG and TG.46 The probable reasons for the difference between some of these findings and our results are that women in the mentioned study had android obesity (BMI = 30.4 kg/m2), older age (mean age = 59.5 years), and higher waist circumference (mean 102.1 cm) than our subjects. It is well known that hormonal and sedentary impacts of menopause are associated with glucose intolerance, T2D, dyslipidemia, hypertension, and increased risk of cardiovascular diseases.46 In one prospective study, during 3 years of follow-up, investigators observed that butter consumption led to increase TG and decrease HDL-C levels and was directly associated with the risk of MetS.7 Although this report contradicts our findings, it should be noted that the medium butter consumption in that study was 23.5 g/day, which is many times higher than the 1.8 g/day butter intake in ours. One of the strengths of this study compared to previous works which are mostly focused on fat subclasses (SFA, MUFA, PUFA, and TFA) is attention to the pattern of consumption; it makes the results more suitable for presentation to the public as practical health advice. The present study also had several limitations that should be mentioned. Firstly, given the questionnaire-based nature of this study, the results may have been affected by recall bias and information bias. Also, like other observational studies, it is impossible to mention a cause-and-effect relationship. Although much effort was made to minimize the effect of confounding variables, residual confounders, whose effects cannot be ignored, may still influence the results.

Conclusions

This study indicated the inverse relationship between Kermanshah ghee and butter consumption with MetS and some of its components. Therefore, consumption of milk-based oils may be associated with lower cardiovascular risk factors. However, clinical trials are required to recommend the most effective dosages.
  37 in total

1.  Effects of margarines and butter consumption on lipid profiles, inflammation markers and lipid transfer to HDL particles in free-living subjects with the metabolic syndrome.

Authors:  A C M Gagliardi; R C Maranhão; H P de Sousa; E J Schaefer; R D Santos
Journal:  Eur J Clin Nutr       Date:  2010-07-21       Impact factor: 4.016

2.  Acute effects of epigallocatechin gallate from green tea on oxidation and tissue incorporation of dietary lipids in mice fed a high-fat diet.

Authors:  M Friedrich; K J Petzke; D Raederstorff; S Wolfram; S Klaus
Journal:  Int J Obes (Lond)       Date:  2011-07-12       Impact factor: 5.095

3.  Total and Full-Fat, but Not Low-Fat, Dairy Product Intakes are Inversely Associated with Metabolic Syndrome in Adults.

Authors:  Michele Drehmer; Mark A Pereira; Maria Inês Schmidt; Sheila Alvim; Paulo A Lotufo; Vivian C Luft; Bruce B Duncan
Journal:  J Nutr       Date:  2015-10-28       Impact factor: 4.798

4.  Effects of meals rich in either monounsaturated or saturated fat on lipid concentrations and on insulin secretion and action in subjects with high fasting triglyceride concentrations.

Authors:  Sergio Lopez; Beatriz Bermudez; Almudena Ortega; Lourdes M Varela; Yolanda M Pacheco; Jose Villar; Rocio Abia; Francisco J G Muriana
Journal:  Am J Clin Nutr       Date:  2011-01-05       Impact factor: 7.045

5.  Conjugated linoleic acid reduces visceral and ectopic lipid accumulation and insulin resistance in chronic severe hypertriacylglycerolemia.

Authors:  Hana Malinska; Martina Hüttl; Olena Oliyarnyk; Miriam Bratova; Ludmila Kazdova
Journal:  Nutrition       Date:  2015-04-20       Impact factor: 4.008

6.  Dairy Consumption Lowers Systemic Inflammation and Liver Enzymes in Typically Low-Dairy Consumers with Clinical Characteristics of Metabolic Syndrome.

Authors:  Christine E Dugan; David Aguilar; Young-Ki Park; Ji-Young Lee; Maria Luz Fernandez
Journal:  J Am Coll Nutr       Date:  2015-11-23       Impact factor: 3.169

7.  Butyrate improves insulin sensitivity and increases energy expenditure in mice.

Authors:  Zhanguo Gao; Jun Yin; Jin Zhang; Robert E Ward; Roy J Martin; Michael Lefevre; William T Cefalu; Jianping Ye
Journal:  Diabetes       Date:  2009-04-14       Impact factor: 9.461

8.  First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran.

Authors:  Alireza Delavari; Mohammad Hossein Forouzanfar; Siamak Alikhani; Afsaneh Sharifian; Roya Kelishadi
Journal:  Diabetes Care       Date:  2009-03-11       Impact factor: 19.112

9.  Comparison of 3 Nutritional Questionnaires to Determine Energy Intake Accuracy in Iranian Adults.

Authors:  Shima Moradi; Yahya Pasdar; Behrooz Hamzeh; Farid Najafi; Seyed Mostafa Nachvak; Roghayeh Mostafai; Parisa Niazi; Mansour Rezaei
Journal:  Clin Nutr Res       Date:  2018-07-30

Review 10.  Dairy Fat Consumption and the Risk of Metabolic Syndrome: An Examination of the Saturated Fatty Acids in Dairy.

Authors:  Allison L Unger; Moises Torres-Gonzalez; Jana Kraft
Journal:  Nutrients       Date:  2019-09-12       Impact factor: 5.717

View more
  1 in total

1.  Association of Tibetan Habitual Food and Metabolic Syndrome Among Tibetan People in China: A Cross-Sectional Study.

Authors:  Kehan Li; Qiang Zhang; Hui Cai; Ruifeng He; Qucuo Nima; Yajie Li; Deji Suolang; Zhuoga Cidan; Pingcuo Wangqing; Xing Zhao; Jingzhong Li; Qiaolan Liu
Journal:  Front Nutr       Date:  2022-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.